F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 44 filers reported holding F-STAR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,645,888 | +23.4% | 576,881 | 0.0% | 1.03% | +29.2% |
| Q3 2022 | $2,954,000 | -18.2% | 576,881 | 0.0% | 0.80% | -19.2% |
| Q2 2022 | $3,611,000 | +46.6% | 576,881 | -16.9% | 0.98% | +53.3% |
| Q1 2022 | $2,463,000 | -29.3% | 693,785 | 0.0% | 0.64% | -26.7% |
| Q4 2021 | $3,483,000 | -31.4% | 693,785 | 0.0% | 0.88% | -35.0% |
| Q3 2021 | $5,079,000 | -17.2% | 693,785 | -2.9% | 1.35% | +5.0% |
| Q2 2021 | $6,136,000 | – | 714,285 | – | 1.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 574,996 | $2,944,000 | 1.06% |
| AlphaCentric Advisors LLC | 165,000 | $845,000 | 0.87% |
| DAFNA Capital Management LLC | 576,881 | $2,954,000 | 0.80% |
| Knott David M Jr | 235,945 | $1,208,000 | 0.51% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3,070,000 | 0.34% |
| S. MUOIO & CO. LLC | 40,000 | $205,000 | 0.27% |
| Murchinson Ltd. | 162,624 | $833,000 | 0.24% |
| Connolly Sarah T. | 53,001 | $271,000 | 0.20% |
| BCK CAPITAL MANAGEMENT LP | 52,000 | $266,000 | 0.19% |
| Diametric Capital, LP | 44,449 | $228,000 | 0.12% |